Lista de obras - Antonia Martinetti - Dominio Público Uruguay

A multicentre, randomized, pharmacokinetic, endocrine and clinical study to evaluate formestane in breast cancer patients at first relapse: Endocrine and clinical results

scientific article published on 01 July 1997

A randomized, multicenter prospective trial assessing long-acting release octreotide pamoate plus tamoxifen as a first line therapy for advanced breast carcinoma

artículo científico publicado en 2002

Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?

artículo científico publicado en 2006

Biological activity of anastrozole in postmenopausal patients with advanced breast cancer: effects on estrogens and bone metabolism

artículo científico publicado en 2002

Body mass index and clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer

artículo científico publicado en 2016

Can bone metabolism markers be adopted as an alternative to scintigraphic imaging in monitoring bone metastases from breast cancer?

scientific article published on 01 November 1997

Circulating CA125 in Patients with Peritoneal Mesothelioma Treated with Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion

scientific article published on 06 December 2006

Circulating biomarkers in advanced colorectal cancer patients randomly assigned to three bevacizumab-based regimens

artículo científico publicado en 2014

Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS-BRAF wild-type colorectal cancer receiving cetuximab or panitumumab.

artículo científico publicado en 2015

DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan

artículo científico publicado en 2015

Development of a Protocol for Single-Cell Analysis of Circulating Tumor Cells in Patients with Solid Tumors.

artículo científico publicado en 2017

Diagnostic and prognostic tumor markers in the gastrointestinal tract.

artículo científico publicado en 2001

Did Circulating Tumor Cells Tell us all they Could? The Missed Circulating Tumor Cell Message in Breast Cancer

artículo científico publicado en 2015

Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses, in postmenopausal breast cancer patients1Accepted as a poster presentation to the 34th Annual Meeting of the American Society of Clinical Oncology, May 1998, Los Ang

scientific article published on 01 February 1999

Effect of 10-day broccoli consumption on inflammatory status of young healthy smokers

artículo científico publicado en 2013

Effect of a Tomato Drink Intervention on Insulin-Like Growth Factor (IGF)-1 Serum Levels in Healthy Subjects

artículo científico publicado en 2006

Effect of broccoli intake on markers related to oxidative stress and cancer risk in healthy smokers and nonsmokers

artículo científico publicado en 2009

Effect of two 4-hydroxyandrostenedione doses on serum insulin-like growth factor I levels in advanced breast cancer

artículo científico publicado en 1994

Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours

artículo científico publicado en 2002

Endocrinological and clinical evaluation of exemestane, a new steroidal aromatase inhibitor.

artículo científico publicado en 1995

Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer.

artículo científico

IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients

artículo científico publicado en 2017

Lanreotide autogel every 6 weeks compared with Lanreotide microparticles every 3 weeks in patients with well differentiated neuroendocrine tumors: a Phase III Study

artículo científico publicado en 2006

Osteopontin, E-cadherin, and β-catenin expression as prognostic biomarkers in patients with radically resected gastric cancer.

artículo científico publicado en 2015

Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole

artículo científico publicado en 2004

Phase II study of pemetrexed disodium (Alimta) administered with oral folic acid in patients with advanced gastric cancer

artículo científico publicado en 2003

Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

artículo científico publicado en 2007

Role of the antiangiogenic agent bevacizumab in the treatment of elderly patients with metastatic colorectal cancer

artículo científico publicado en 2011

Safety and activity of sorafenib in different histotypes of advanced renal cell carcinoma

artículo científico publicado en 2007

Serum soluble urokinase-type plasminogen activator receptor as a serum marker of inflammatory response that leads to tissue damage and surgical complication

artículo científico publicado en 2016

Short-term effects of anastrozole treatment on insulin-like growth factor system in postmenopausal advanced breast cancer patients

artículo científico publicado en 2002

Testosterone, dihydrotestosterone and oestradiol levels in postmenopausal breast cancer tissues

scientific article published on 01 June 1995

The aromatase inhibitor letrozole in advanced breast cancer: Effects on serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels

artículo científico publicado en 1997

The estrogen suppression after sequential treatment with formestane in advanced breast cancer patients

artículo científico publicado en 2004

The luteinising hormone–releasing hormone analogue triptorelin with or without the aromatase inhibitor formestane in premenopausal breast cancer: effects on bone metabolism markers

artículo científico publicado en 2000

The minimal effective exemestane dose for endocrine activity in advanced breast cancer

artículo científico publicado en 1997

Tumor response and estrogen suppression in breast cancer patients treated with aromatase inhibitors

artículo científico publicado en 2000

Undetected toxicity risk in pharmacogenetic testing for dihydropyrimidine dehydrogenase

artículo científico publicado en 2015

Urinary testosterone as a marker of risk of recurrence in operable breast cancer

scientific article published on 01 January 1993

Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab.

artículo científico publicado en 2016

c-erbB 2 Serum level as prognostic factor in hormonally treated advanced breast cancer patients

artículo científico publicado en 2002

Lista de obras de Antonia Martinetti

A multicentre, randomized, pharmacokinetic, endocrine and clinical study to evaluate formestane in breast cancer patients at first relapse: Endocrine and clinical results

A randomized, multicenter prospective trial assessing long-acting release octreotide pamoate plus tamoxifen as a first line therapy for advanced breast carcinoma

Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?

Biological activity of anastrozole in postmenopausal patients with advanced breast cancer: effects on estrogens and bone metabolism

Body mass index and clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer

Can bone metabolism markers be adopted as an alternative to scintigraphic imaging in monitoring bone metastases from breast cancer?

Circulating CA125 in Patients with Peritoneal Mesothelioma Treated with Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion

Circulating biomarkers in advanced colorectal cancer patients randomly assigned to three bevacizumab-based regimens

Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS-BRAF wild-type colorectal cancer receiving cetuximab or panitumumab.

DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan

Development of a Protocol for Single-Cell Analysis of Circulating Tumor Cells in Patients with Solid Tumors.

Diagnostic and prognostic tumor markers in the gastrointestinal tract.

Did Circulating Tumor Cells Tell us all they Could? The Missed Circulating Tumor Cell Message in Breast Cancer

Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses, in postmenopausal breast cancer patients1Accepted as a poster presentation to the 34th Annual Meeting of the American Society of Clinical Oncology, May 1998, Los Ang

Effect of 10-day broccoli consumption on inflammatory status of young healthy smokers

Effect of a Tomato Drink Intervention on Insulin-Like Growth Factor (IGF)-1 Serum Levels in Healthy Subjects

Effect of broccoli intake on markers related to oxidative stress and cancer risk in healthy smokers and nonsmokers

Effect of two 4-hydroxyandrostenedione doses on serum insulin-like growth factor I levels in advanced breast cancer

Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours

Endocrinological and clinical evaluation of exemestane, a new steroidal aromatase inhibitor.

Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer.

IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients

Lanreotide autogel every 6 weeks compared with Lanreotide microparticles every 3 weeks in patients with well differentiated neuroendocrine tumors: a Phase III Study

Osteopontin, E-cadherin, and β-catenin expression as prognostic biomarkers in patients with radically resected gastric cancer.

Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole

Phase II study of pemetrexed disodium (Alimta) administered with oral folic acid in patients with advanced gastric cancer

Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Role of the antiangiogenic agent bevacizumab in the treatment of elderly patients with metastatic colorectal cancer

Safety and activity of sorafenib in different histotypes of advanced renal cell carcinoma

Serum soluble urokinase-type plasminogen activator receptor as a serum marker of inflammatory response that leads to tissue damage and surgical complication

Short-term effects of anastrozole treatment on insulin-like growth factor system in postmenopausal advanced breast cancer patients

Testosterone, dihydrotestosterone and oestradiol levels in postmenopausal breast cancer tissues

The aromatase inhibitor letrozole in advanced breast cancer: Effects on serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels

The estrogen suppression after sequential treatment with formestane in advanced breast cancer patients

The luteinising hormone–releasing hormone analogue triptorelin with or without the aromatase inhibitor formestane in premenopausal breast cancer: effects on bone metabolism markers

The minimal effective exemestane dose for endocrine activity in advanced breast cancer

Tumor response and estrogen suppression in breast cancer patients treated with aromatase inhibitors

Undetected toxicity risk in pharmacogenetic testing for dihydropyrimidine dehydrogenase

Urinary testosterone as a marker of risk of recurrence in operable breast cancer

Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab.

c-erbB 2 Serum level as prognostic factor in hormonally treated advanced breast cancer patients